Healthcare SpotlightCDSCO Withdraws COVID-19 Indication For Baricitinib Tablet At Eli Lilly’s RequestBY Archana Jyoti
NationalCDSCO Investigation Exposes Regulatory Lapses In Coldrif Cough Syrup CaseBY Outlook News Desk
NationalCDSCO Report Reveals Alarming Contamination Levels In Indian Allergy And Cough SyrupsBY Outlook News Desk
NationalBharat Biotech Recalls Batch Of Typhoid Vaccines After Being Flagged Over Quality IssuesBY Outlook News Desk
NationalHimachal Pradesh: How Spurious Drugs Have Brought Bad Name, Regulatory Spotlight On State’s Famed Pharma IndustryBY Ashwani Sharma
NationalIndia Takes Pride In Being ‘Pharmacy Of The World’ But Cough Syrup, Eye Drop Deaths Tell A Different StoryBY Rakhi Bose
NationalUzbekistan Deaths: India Starts Probing Marion Biotech, What We Know So Far Of Syrup ControversyBY Outlook News Desk
InternationalCentre Starts Probe After WHO Claims Indian Cough Syrups Behind 66 Deaths In The GambiaBY Outlook News Desk
NationalCDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine CovovaxBY Outlook News Desk
NationalCovaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 MonthsBY Outlook News Desk